by The global infertility drugs market size was exhibited at USD 3.71 billion in 2023 and is predicted to rise around USD 6.73 billion by 2033, growing at a CAGR of 6.13% from 2024 to 2033.
Key Points
- The global infertility drugs market size accounted for USD 1.45 billion in 2023 and is expected to rise around USD 2.65 billion by 2033.
- North America dominated the market with the largest market share of 39% in 2023.
- Asia Pacific is expected to expand at the fastest CAGR of 6.93% during the forecast period.
- By drug class, the gonadotropins segment has contributed more than 41% of market share in 2023.
- By the drug class, the selective estrogen receptor modulators segment is predicted to show rapid growth in the market.
- By the distribution channel, the hospital pharmacy segment has generated more than 55% of market share in 2023.
- By distribution channel, the online pharmacy segment is expected to grow at a high rate over the forecast period.
- By end-user, the women segment has contributed more than 74% of market share in 2023.
- By end-user, the men segment will be the fastest-growing segment during the forecast period.
The global infertility drugs market is a dynamic sector driven by increasing infertility rates worldwide and advancements in reproductive medicine. Infertility drugs encompass a range of medications designed to stimulate ovulation, regulate hormonal imbalances, and treat underlying causes of infertility. This market is characterized by a growing demand for assisted reproductive technologies (ART) and rising awareness about infertility treatments.
Get a Sample: https://www.precedenceresearch.com/sample/4243
Growth Factors
Several factors contribute to the growth of the infertility drugs market. Firstly, rising infertility rates due to factors such as age-related fertility decline, lifestyle changes, and environmental factors are driving demand for fertility treatments. Secondly, technological advancements in reproductive medicine, including the development of more effective and targeted infertility drugs, are expanding treatment options and improving success rates. Additionally, increasing acceptance of ART and fertility treatments is boosting market growth globally.
Region Insights
The infertility drugs market shows regional variations in terms of adoption rates and regulatory environments. Developed regions like North America and Europe have well-established markets with high adoption rates of infertility treatments due to better healthcare infrastructure and higher awareness levels. Emerging markets in Asia-Pacific and Latin America are witnessing rapid growth due to improving healthcare access, increasing disposable incomes, and changing societal attitudes towards infertility treatments.
Infertility Drugs Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 6.13% |
| Global Market Size in 2023 | USD 3.71 Billion |
| Global Market Size in 2024 | USD 3.94 Billion |
| Global Market Size by 2033 | USD 6.73 Billion |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Drug Class, By Distribution Channel, and By End-user |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Infertility Drugs Market Dynamics
Drivers
Key drivers of the infertility drugs market include growing infertility prevalence, especially among older populations, and lifestyle factors such as obesity and stress. Advancements in diagnostic technologies enable early detection and treatment of infertility issues, further propelling market growth. Moreover, supportive government initiatives and insurance coverage for infertility treatments in some regions contribute to market expansion.
Opportunities
The infertility drugs market presents opportunities for innovation and market expansion. Collaborations between pharmaceutical companies and research institutions can lead to the development of novel infertility drugs with improved efficacy and safety profiles. Expanding into underserved markets and offering affordable treatment options can tap into unmet needs and drive revenue growth. Moreover, increasing awareness campaigns and educational efforts can further enhance market acceptance and adoption.
Challenges
Despite growth prospects, the infertility drugs market faces challenges such as stringent regulatory frameworks governing reproductive medicine, particularly in emerging markets. High treatment costs and limited insurance coverage in certain regions pose affordability challenges for patients seeking infertility treatments. Additionally, ethical considerations and societal stigmas associated with fertility treatments can create barriers to market expansion and patient acceptance.
Read Also: Calcium Peroxide Market Size to Rise USD 3.38 Bn By 2033
Infertility Drugs Market Recent Developments
- In February 2024, Lupin, a major global pharma company, launched Ganirelix Acetate Injection. It is a single-dose prefilled syringe indicated for inhibiting premature luteinizing hormone (LH) surges in women who undergo ovarian hyperstimulation.
- In March 2024, Future Generali India Insurance launched ‘Health PowHER’, a product designed exclusively for women healthcare at various stages of their lives. There will be varios treatments offered by the product, and one of the treatments will be infertility treatment. This will include oocyte cryopreservation, stem cell storage, wellness programme, insurance for newborn defects, nursing care, and many more benefits.
Infertility Drugs Market Companies
- Merck & Co., Inc.
- Ferring B.V.
- Organon Group of Companies
- Abbott
- Novartis AG
- Bayer AG
- Pfizer Inc.
- Mankind Pharma
- Teva Pharmaceutical Industries LTD.
- Sanofi
Segments Covered in the Report
By Drug Class
- Gonadotropins
- Aromatase Inhibitors
- Selective Estrogen Receptor Modulators (SERMs)
- Dopamine Agonists
- Others
By Distribution Channel
- Hospital Pharmacy
- Specialty & Retail Pharmacy
- Online Pharmacy
By End-user
- Men
- Women
By Geography
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East & Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
